MD Biosciences, Kingsray Bio lead domestic and foreign CRO enterprises to debut 2014 China (Nanjing) International Biopharmaceutical Industry Expo

Business Agency, February 17 () With the expiration of many drug patents, biopharmaceutical outsourcing services, also known as the Contract Research Organization (COW), has become more important, is the past 20 years with the changes in the biopharmaceutical research and development chain and the industry chain rapidly formed a new high-end service industrycurrently, globally, CRO companies have undertaken nearly one-third of the new drug development work, the market size of the annual rate of 20-25% expansionThe world's large-scale CRO are set up branches in China, will be part of the business to the domestic branch to complete, of which, Nanjing is an important destinationNanjing Jiangning Science Park investment and construction of 30,000 square meters of experimental base put into use, but also attracted biologicalpharmaceuticalupstream and downstream enterprises into the park, Nanjing Kingsray Biotech Co., Ltdis one of the enterprise development momentum is particularly prominentbioCRO has become the focus of global attention, the scale of the global market is developing rapidlyOn May 14-16, 2014, the China (Nanjing) International Biopharmaceutical Industry Expo, co-sponsored by the Nanjing Municipal People's Government Exhibition And Exhibition Office, the National Association of Pharmaceutical Technology Market, and the ChinaHealthIndustry Development Alliance, not only provides the opportunity for CRO enterprises to display and joinequipment
equipment, pharmaceutical environmental protection and clean technology, analytical and testing equipment, pharmaceutical software and otherenterprisespavilion It is reported that many well-known CRO enterprises at home and abroad will also be present for product display, including from Israel's well-known CRO company MD Biosciences and the world's first gene synthesis service provider Nanjing Kingsray Biotech Co., Ltd pre-registered exhibit free of charge! For more information on the of the exhibition, please contact Nanjing Pushang Business Management Co., Ltd.: Contact: Huang Hao
Tel: 025-83418350 18652988502
fax: 025-83518322-818; Email: bio_huangh@126.com
: MD Biosciences
MD Biosciences is a pre-clinical contract research organization (CRO) providing in vitro and in vivo nonclinical yn dysiar as well as a clinical bio bio marker and general chemistry analysis Ao focus is on, and cardi gylys Our approach is to understand the need in clinic and work backwards In this way, we look to develop new methods for preclinical testing as well as new biomarkers that can be used in the clinical set to improve the current current methods.
Nanjing Kingsley Biotech Co., Ltd introduced Nanjing Kingsley Biotech Co., Ltd (formerly Kingstey Technology (Nanjing) Co., Ltd.) was founded in 2002, with the development of synthetic biology and rapid growth, has become the world's largest supplier of genetic synthesis Headquartered in New Jersey, the company has offices in Europe, Japan and China Kingsley is committed to providing the best research services to research institutions around the world In addition to the world's leading gene synthesis services, Kingsley offers technical services related to bioreta research and new drug development, including bioreta customization, drug screening and high-throughput screening, antibody drug development, and model animal services By developing and applying innovative synthetic biology technologies, Kingsley is committed to helping researchers accelerate research in the field of biology